For many years, researchers have been working to figure out a way to win the battle with a common form of dementia: Alzheimer’s disease. One clue comes from epidemiology studies associating “good fats”, such as Omega-3 fatty acids, with lower risk of Alzheimer’s disease. However, clinical trials of omega-3 supplements on cognition have largely been negative. How do we explain this paradox? The Yassine lab studies the factors that make omega-3 supplements more likely to affect cognition when added to the diet. You can find additional information provided by Dr. Yassine, in an interview with Dr. Isaacson conducted by Medscape regarding this matter.